Differentiation of Nk1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2648-2656

  Williams, Noelle Sevilir ^a   Klem, Jennifer ^a,b   Puzanov, Igor J ^a,b   Sivakumar, P V ^a,b   Bennett, Michael ^a   Kumar, Vinay ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; INTERLEUKIN 15; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; STROMA CELL;

ANIMALS; ANTIGENS; ANTIGENS, LY; ANTIGENS, SURFACE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; COCULTURE TECHNIQUES; FMS-LIKE TYROSINE KINASE 3; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-15; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; LYMPHOCYTE SUBSETS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, SCID; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR PROTEIN-TYROSINE KINASES; STROMAL CELLS;

EID: 0033197973     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Sivakumar, P. V., I. Puzanov, N. S. Williams, M. Bennett, and V. Kumar. 1998. Ontogeny and differentiation of murine natural killer cells and their receptors. In Specificity, Function, and Development of NK Cells, Vol. 230. K. Kärre and M. Colonna, eds. Springer-Verlag, Berlin, p. 161.
2. Lanier, L. L., C. Chang, M. Azuma, J. J. Ruitenberg, J. J. Hemperly, and J. H. Phillips. 1991. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J. Immunol. 91:4421.
3. Lanier, L. L. 1997. Natural killer cells: from no receptors to too many. Immunity 6:371.
4. + IL-2 activated natural killer cells. Nature 358:66.
5. Moretta, A., S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, J. C. Bottino, and L. Moretta. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182:875.
6. Mason, L. H., S. K. Anderson, W. M. Yokoyama, H. R. C. Smith, R. Winkler-Pickett and J. R. Ortaldo. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184:2119.
7. - bone marrow progenitors. J. Immunol. 150:5263.
8. + hematopoietic progenitor cells. Blood 87:2632.
9. + hematopoietic progenitor cells. Blood 85:3538.
10. Silva, M. R. G., R. Hoffman, E. F. Srour, and J. L. Ascensao. 1994. Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood 84:841.
11. - functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J. Exp. Med. 184:1845.
12. Yu, H., T. A. Fehniger, P. Fuchshuber, K. S. Thiel, E. Vivier, W. E. Carson, and M. A. Caligiuri. 1998. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 92:3647.
13. d anemic mice. Exp. Hematol. 9:691.
14. Hackett, J., Jr., M. Bennett, and V. Kumar. 1985. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor. J. Immunol. 134: 3731.
15. Lyman, S. D., L. James, T. Vanden Bos, P. de Vries, K. Brasel, B. Gliniak, L. T. Hollingsworth, K. S. Picha, H. J. McKenna, R. R. Splett, et al. 1993. Molecular cloning of a ligand for the flt3/fltk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75:1157.
16. Lisovsky, M., S. E. Braun, Y. Ge, H. Takahira, L. Lu, V. G. Savchenko, S. D. Lyman, and H. E. Broxmeyer. 1996. Flt3-ligand production by human bone marrow stromal cells. Leukemia 10:1012.
17. Jacobsen, S. E., C. Okkenhaug, J. Mykleburst, O. P. Veiby, and S. D. Lyman. 1995. The flt3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL)-11, IL-12, and other hematopoietic growth factors. J. Exp. Med. 181:1358.
18. + hematopoietic progenitor cells. Blood 9:3413.
19. Namikawa, R., M. O. Muench, J. E. de Vries, and M.-G. Roncarolo. 1996. The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 5:1881.
20. Yonemura, Y., H. Ku, S. D. Lyman, and M. Ogawa. 1997. In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/ FLK-2 ligand and KIT ligand. Blood 6:1915.
21. Brasel, K., H. J. McKenna, P. J. Morrissey, K. Charrier, A. E. Morris, C. C. Lee, D. E. Williams, and S. D. Lyman. 1996. Hematologic effects of flt3 ligand in vivo in mice. Blood 88:2004.
22. Shaw, S. G., A. A. Maung, R. J. Steptoe, A. W. Thomson, and N. L. Vujanovic. 1998. Expansion of functional NK cells in multiple tissue compartments of mice treated with flt3-ligand: implications for anti-cancer and anti-viral therapy. J. Immunol. 161: 2817.
23. McKenna, H. J., R. E. Miller, K. Brasel, E. Maraskovsky, C. Maliszewski, B. Pulendran, D. Lynch, M. Teepe, E. R. Roux, J. Smith, et al. 1996. Targeted disruption of the flt3 ligand gene in mice affects multiple hematopoietic lineages, including natural killer cells, B lymphocytes, and dendritic cells. Blood 88:474a (Abstr.).
24. - cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med. 186:1609.
25. Kodama, H., M. Nose, S. Niida, S. Nishikawa, and S.-I. Nishikawa. 1994. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells Exp. Hematol. 22:979.
26. - cells: a possible mechanism of tolerance during NK cell development. J. Immunol. 162:6976.
27. Siegel, S. 1956. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill Book Co., New York.
28. + T cells, but not for natural killer cells. J. Exp. Med. 184:289.
29. -/- mice. J. Immunol. 157:2366.
30. Williams, N. S., J. Klem, I. J. Puzanov, P. V. Sivakumar, J. D. Schatzle, M. Bennett, and V. Kumar. 1998. Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems. Immunol. Rev. 165:47.
31. Mingari, M. C., C. Vitale, C. Cantoni, R. Bellomo, M. Ponte, F. Schiavetti, S. Bertone, A. Moretta, and L. Moretta. 1997. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27:1374.
32. Bennett, M. 1972. Rejection of marrow allografts: importance of H-2 homozygosity of donor cells. Transplantation 14:289.
33. Haller, O., and H. Wigzell. 1977. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J. Immunol. 118:1503.
34. Mason, L. H., J. R. Ortaldo, H. A. Young, V. Kumar, M. Bennett, and S. K. Anderson. 1995. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J. Exp. Med. 182:293.
35. Brennan, J., S. Lemieux, J. D. Freeman, D. L. Mager, and F. Takei. 1996. Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with differing functions and expression patterns. J. Exp. Med. 184:2085.
36. Roland, J., and P. A. Cazenave. 1992. Ly-49 antigen defines an αβ TCR population of i-IEL with an extrathymic maturation. Int. Immunol. 4:699.
37. Mason, L. H., J. Willette-Brown, S. K. Anderson, P. Gosselin, E. W. Shores, P. E. Love, J. R. Ortaldo, and D. W. McVicar. 1998. Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J. Immunol. 160:4148.
38. Puzanov, I. J., M. Bennett, and V. Kumar. 1996. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 157:4282.
39. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669.
40. Kennedy, M. K., M. B. Glaccum, K. A. Brasel, M. E. Embers, S. N. Brown, C. R. Willis, K. Charrier, P. J. Morrissey, S. Joyce, and J. J. Peschon. 1998. Impaired development of natural killer cells and natural T cells in IL-15-deficient mice. Proceedings of the 10th International Congress of Immunology. The Immunologist. Suppl. 1:159(Abstr.).
41. Chen, K., S. Braun, S. Lyman, Y. Fan, C. M. Traycoff, E. A. Wiebke, J. Gaddy, G. Sledge, H. E. Broxmeyer, and K. Cornetta. 1997. Antitumor activity and immunotherapeutic properties of flt3-ligand in a murine breast cancer model. Cancer Res., 57:3511.
42. Esche, C., V. M. Subbotin, C. Maliszewski, M. T. Lotze, and M. R. Shurin. 1998. Flt3 ligand administration inhibits tumor growth in murine melanoma and lymphoma. Cancer Res. 58:380.
43. Péron, J.-M., C. Esche, V. M. Subbotin, C. Maliszewski, M. T. Lotze, and M. R. Shurin. 1998. Flt3-ligand administration inhibits liver metastases: role of NK cells. J. Immunol. 161:6164.
44. Lynch, D. H. 1998. Induction of dendritic cells (DC) by flt3 ligand (FL) promotes the generation of tumor-specific immune responses in vivo. Crit. Rev. Immunol. 18:99.
45. - cells can distinguish the presence and absence of class I on target cells: evidence for a Ly-49-independent negative signaling receptor. Eur. J. Immunol. 27:3100.
46. Dorfman, J. R., and D. H. Raulet. 1998. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 187:609.
47. Raulet, D. H., W. Held, I. Correa, J. R. Dorfman, M.-F. Wu, and L. Corral. 1997. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155:41.
48. Brennan, J., D. Mager, W. Jefferies, and F. Takei. 1994. Expression of different members of the Ly-49 family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180:2287.